ASX - By Stock
|
LPM |
Re:
Ann: Maiden High-Grade Lithium Resource declared at Lei
|
|
arkus
|
104 |
34K |
4 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
104
|
34K
|
4
|
|
ASX - By Stock
|
LPM |
Re:
Ann: Maiden High-Grade Lithium Resource declared at Lei
|
|
arkus
|
104 |
34K |
4 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
104
|
34K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Change of Director's Interest Notice PHa
|
|
arkus
|
6 |
2.3K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
6
|
2.3K
|
0
|
|
ASX - By Stock
|
OM1 |
Re:
Ann: Suspension from Quotation
|
|
arkus
|
60 |
24K |
4 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
60
|
24K
|
4
|
|
ASX - By Stock
|
NYM |
Re:
Spodumene Island
|
|
arkus
|
82 |
25K |
0 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
82
|
25K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
arkus
|
44 |
12K |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Questions for webinar
|
|
arkus
|
14 |
4.3K |
0 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
14
|
4.3K
|
0
|
|
ASX - By Stock
|
SLB |
Re:
Ann: Drilling completed at Trident Lithium Project
|
|
arkus
|
26 |
6.7K |
0 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
26
|
6.7K
|
0
|
|
ASX - By Stock
|
SLB |
Re:
Ann: Drilling completed at Trident Lithium Project
|
|
arkus
|
26 |
6.7K |
5 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
26
|
6.7K
|
5
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Prospectus
|
|
arkus
|
56 |
8.0K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
56
|
8.0K
|
1
|
|
ASX - By Stock
|
FTL |
Re:
Ann: New LCT pegmatite targets identified at Yalgoo
|
|
arkus
|
1 |
557 |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
1
|
557
|
0
|
|
ASX - By Stock
|
OM1 |
Re:
Ann: Change of Director's Interest Notice
|
|
arkus
|
2 |
1.0K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
OM1 |
Re:
Ann: Trading Halt
|
|
arkus
|
146 |
45K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
146
|
45K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
arkus
|
79 |
19K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
19K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
arkus
|
79 |
19K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
19K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
arkus
|
79 |
19K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
19K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
arkus
|
79 |
19K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
19K
|
3
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Update - Proposed issue of securities - LRV
|
|
arkus
|
5 |
1.1K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
5
|
1.1K
|
0
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Options Prospectus
|
|
arkus
|
5 |
2.5K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
NYM |
Re:
Ann: Canadian Lithium Exploration Update
|
|
arkus
|
4 |
1.7K |
0 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
4
|
1.7K
|
0
|
|
ASX - By Stock
|
SLB |
Re:
General Comments
|
|
arkus
|
212 |
117K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
212
|
117K
|
4
|
|
ASX - By Stock
|
SLB |
Re:
General Comments
|
|
arkus
|
212 |
117K |
2 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
212
|
117K
|
2
|
|
ASX - By Stock
|
NYM |
Re:
Spodumene Island
|
|
arkus
|
82 |
25K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
82
|
25K
|
1
|
|
ASX - By Stock
|
LPM |
Re:
Ann: LEI DISCOVERY SAMPLES DISPATCHED FOR METALLURGICAL TESTING
|
|
arkus
|
29 |
9.6K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
29
|
9.6K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Results of Annual General Meeting
|
|
arkus
|
12 |
3.8K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
12
|
3.8K
|
0
|
|
ASX - By Stock
|
FTL |
Re:
Ann: Encouraging First Assay Results from Picha Copper Project
|
|
arkus
|
19 |
6.7K |
6 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
19
|
6.7K
|
6
|
|
ASX - By Stock
|
WBE |
Re:
Ann: Strategic Option Process Attracts Significant Early Interest
|
|
arkus
|
6 |
1.9K |
0 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
6
|
1.9K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
|
|
arkus
|
56 |
18K |
3 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
56
|
18K
|
3
|
|
ASX - By Stock
|
FTL |
Re:
Ann: Farm-in Agreement Completed on Yalgoo Lithium Project
|
|
arkus
|
1 |
598 |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
1
|
598
|
0
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Encouraging Results from Drilling at Eyre's Ni Li Project
|
|
arkus
|
48 |
11K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
48
|
11K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
arkus
|
99 |
31K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
99
|
31K
|
2
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Suspension from Quotation
|
|
arkus
|
35 |
7.3K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
35
|
7.3K
|
0
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Exploration Manager Appointed
|
|
arkus
|
22 |
3.8K |
2 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
22
|
3.8K
|
2
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Suspension from Quotation
|
|
arkus
|
35 |
7.3K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
35
|
7.3K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
arkus
|
70 |
20K |
8 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
arkus
|
70 |
20K |
5 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
arkus
|
70 |
20K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
arkus
|
99 |
31K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
99
|
31K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
arkus
|
99 |
31K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
arkus
|
99 |
31K |
3 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
arkus
|
99 |
31K |
5 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
99
|
31K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
arkus
|
75 |
25K |
11 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
75
|
25K
|
11
|
|
ASX - By Stock
|
LRV |
Re:
Ann: Trading Halt
|
|
arkus
|
200 |
34K |
0 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
200
|
34K
|
0
|
|
ASX - By Stock
|
OM1 |
Re:
Ann: CONTRACTOR SECURED FOR DRILLING CAMPAIGN - LAC DES MONTAGNES
|
|
arkus
|
38 |
9.8K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
38
|
9.8K
|
1
|
|
ASX - By Stock
|
LPM |
Re:
Ann: 94M of High-Grade Mineralisation confirmed at Lei
|
|
arkus
|
220 |
62K |
8 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
220
|
62K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
arkus
|
684 |
270K |
0 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
684
|
270K
|
0
|
|
ASX - By Stock
|
OM1 Lithium |
Re:
OM1 General discussion
|
|
arkus
|
108 |
34K |
1 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
108
|
34K
|
1
|
|
ASX - By Stock
|
OM1 Lithium |
Re:
OM1 General discussion
|
|
arkus
|
108 |
34K |
3 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
108
|
34K
|
3
|
|
ASX - By Stock
|
SLB |
Re:
Ann: Trading Halt
|
|
arkus
|
13 |
4.7K |
0 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
13
|
4.7K
|
0
|
|
ASX - By Stock
|
SLB |
Re:
Ann: Trading Halt
|
|
arkus
|
13 |
4.7K |
0 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
13
|
4.7K
|
0
|
|